{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:11:23Z","timestamp":1760044283421},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[1979,12,1]],"date-time":"1979-12-01T00:00:00Z","timestamp":312854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Agents and Actions"],"published-print":{"date-parts":[[1979,12]]},"DOI":"10.1007\/bf01968116","type":"journal-article","created":{"date-parts":[[2005,8,2]],"date-time":"2005-08-02T04:57:31Z","timestamp":1122958651000},"page":"483-487","source":"Crossref","is-referenced-by-count":15,"title":["Aspirin, salicylate and prostaglandins"],"prefix":"10.1007","volume":"9","author":[{"given":"M. J. H.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. W.","family":"Ford-Hutchinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. R.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Slack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01968116_CR1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-642-66891-3_1","volume-title":"Anti-Inflammatory Drugs","author":"R.J. Gryglewski","year":"1979","unstructured":"R.J. Gryglewski,Screening and Assessment of the Potency of Anti-inflammatory Drugs in vitro, in:Anti-Inflammatory Drugs (Eds. J.R. Vane and S.H. Ferreira; Springer-Verlag, Berlin, 1979), pp. 3\u201343."},{"key":"BF01968116_CR2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-1-4684-2778-3_9","volume-title":"Prostaglandin and Thromboxanes","author":"T.Y. Shen","year":"1977","unstructured":"T.Y. Shen,Prostaglandin Synthetase Inhibitors, in:Prostaglandin and Thromboxanes (Eds. F. Berti, B. Samuelsson and G.P. Velo; Plenum Press, N.Y., 1977), pp. 111\u2013136."},{"key":"BF01968116_CR3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-1-4684-2844-5_12","volume-title":"Prostaglandins in Cellular Biology","author":"A.L. Willis","year":"1972","unstructured":"A.L. Willis, R. Davison, P.W. Ramwell, W.D. Brocklehurst andB. Smith,Release and Actions of Prostaglandins in Inflammation and Fever: Inhibition by Anti-Inflammatory and Antipyretic Drugs, in:Prostaglandins in Cellular Biology (Eds. P.W. Ramwell and B.B. Pharris; Plenum Press, N.Y., 1972), pp. 227\u2013259."},{"key":"BF01968116_CR4","first-page":"105","volume-title":"Advances in Prostaglandin and Thromboxane Research","author":"G.A. Higgs","year":"1976","unstructured":"G.A. Higgs, E.A. Harvey, S.H. Ferreira andJ.R. Vane,The Effects of Anti-Inflammatory Drugs on the Production of Prostaglandins in vivo, in:Advances in Prostaglandin and Thromboxane Research, vol. 1 (Eds. B. Samuelsson and R. Paoletti; Raven Press, N.Y., 1976), pp. 105\u2013110."},{"key":"BF01968116_CR5","first-page":"9","volume-title":"Prostaglandin Synthetase Inhibitors","author":"R.J. Flower","year":"1974","unstructured":"R.J. Flower andJ.R. Vane,Some Pharmacologic and Biochemical Aspects of Prostaglandin Biosynthesis and its Inhibition, in:Prostaglandin Synthetase Inhibitors (Eds. H.J. Robinson and J.R. Vane; Raven Press, N.Y., 1974), pp. 9\u201318."},{"key":"BF01968116_CR6","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.2042-7158.1952.tb13192.x","volume":"4","author":"E. Quilley","year":"1952","unstructured":"E. Quilley andM.J.H. Smith,The Application of Paper Partition Chromatography to the Study of the Metabolism of Salicylate in the Rat, J. Pharm. Pharmac.4, 624\u2013630 (1952).","journal-title":"J. Pharm. Pharmac."},{"key":"BF01968116_CR7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF01968670","volume":"8","author":"M.J.H. Smith","year":"1978","unstructured":"M.J.H. Smith,Aspirin and Prostaglandins, Some Recent Developments, Agents and Actions8, 427\u2013429 (1978).","journal-title":"Agents and Actions"},{"key":"BF01968116_CR8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.2042-7158.1975.tb09487.x","volume":"27","author":"M.J.H. Smith","year":"1975","unstructured":"M.J.H. Smith, A.W. Ford-Hutchinson andP.C. Elliott,Prostaglandins and the Anti-Inflammatory Activities of Aspirin and Sodium Salicylate, J. Pharm. Pharmac.27, 473\u2013478 (1975).","journal-title":"J. Pharm. Pharmac."},{"key":"BF01968116_CR9","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/BF01971577","volume":"6","author":"J.R. Walker","year":"1976","unstructured":"J.R. Walker, M.J.H. Smith andA.W. Ford-Hutchinson,Anti-Inflammatory Drugs, Prostaglandins and Leucocyte Migration, Agents and Actions6, 602\u2013606 (1976).","journal-title":"Agents and Actions"},{"key":"BF01968116_CR10","first-page":"373","volume-title":"Anti-Inflammatory Drugs","author":"S.H. Ferreira","year":"1979","unstructured":"S.H. Ferreira andJ.R. Vane,Mode of Action of Anti-Inflammatory Agents which are Prostaglandin Synthetase Inhibitors, in:Anti-Inflammatory Drugs (Eds. J.R. Vane and S.H. Ferreira; Springer-Verlag, Berlin, 1979), p. 373."},{"key":"BF01968116_CR11","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.2042-7158.1967.tb09600.x","volume":"19","author":"J.A. Sturman","year":"1967","unstructured":"J.A. Sturman andM.J.H. Smith,The Binding of Salicylate to Plasma Proteins in Different Species, J. Pharm. Pharmac.19, 621\u2013623 (1967).","journal-title":"J. Pharm. Pharmac."},{"key":"BF01968116_CR12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/ard.36.3.244","volume":"36","author":"N.S. Doherty","year":"1977","unstructured":"N.S. Doherty, M. Aattila andP.B. Dean,Penetration of Naproxen and Salicylate into Inflammatory Exudates in the Rat, Ann. Rheum. Dis.36, 244\u2013248 (1977).","journal-title":"Ann. Rheum. Dis."},{"key":"BF01968116_CR13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0090-6980(75)90139-2","volume":"9","author":"E.L. Tolman","year":"1975","unstructured":"E.L. Tolman andR. Patridge,Multiple Sites of Interaction between Prostaglandins and Non-Steroidal Anti-Inflammatory Agents, Prostaglandins9, 349\u2013359 (1975).","journal-title":"Prostaglandins"},{"key":"BF01968116_CR14","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.2042-7158.1974.tb09311.x","volume":"26","author":"B. Fjalland","year":"1974","unstructured":"B. Fjalland,Inhibition by Non-Steroidal Anti-Inflammatory Agents of the Release of Rabbit Aorta Contracting Substance and Prostaglandins from Chopped Guinea Pig Lungs, J. Pharm. Pharmac.26, 448\u2013451 (1974).","journal-title":"J. Pharm. Pharmac."},{"key":"BF01968116_CR15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","volume":"231","author":"J.R. Vane","year":"1971","unstructured":"J.R. Vane,Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs, Nature (New Biol.)231, 232\u2013235 (1971).","journal-title":"Nature (New Biol.)"},{"key":"BF01968116_CR16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.2042-7158.1978.tb13171.x","volume":"30","author":"B.B. Vargaftig","year":"1978","unstructured":"B.B. Vargaftig,Salicylic Acid Fails to Inhibit Generation of Thromboxane A 2 Activity after in vivo Administration to the Rat, J. Pharm. Pharmac.30, 101\u2013104 (1978).","journal-title":"J. Pharm. Pharmac."},{"key":"BF01968116_CR17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/BF01966855","volume":"7","author":"A.W. Ford-Hutchinson","year":"1977","unstructured":"A.W. Ford-Hutchinson, J.R. Walker, N.S. Connor andM.J.H. Smith,Prostaglandins and Leucocyte Migration in Inflammatory Reactions, Agents and Actions7, 469\u2013472 (1977).","journal-title":"Agents and Actions"},{"key":"BF01968116_CR18","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/BF01968671","volume":"8","author":"J.R. Vane","year":"1978","unstructured":"J.R. Vane,The Mode of Action of Aspirin-like Drugs, Agents and Actions8, 430\u2013431 (1978).","journal-title":"Agents and Actions"},{"key":"BF01968116_CR19","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.2042-7158.1971.tb08598.x","volume":"23","author":"M.J.H. Smith","year":"1971","unstructured":"M.J.H. Smith andP.D. Dawkins,Salicylate and Enzymes, J. Pharm. Pharmac.23, 729\u2013744 (1971).","journal-title":"J. Pharm. Pharmac."}],"container-title":["Agents and Actions"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01968116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01968116\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01968116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T18:00:49Z","timestamp":1557770449000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01968116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1979,12]]},"references-count":19,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[1979,12]]}},"alternative-id":["BF01968116"],"URL":"https:\/\/doi.org\/10.1007\/bf01968116","relation":{},"ISSN":["0065-4299","1420-908X"],"issn-type":[{"value":"0065-4299","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1979,12]]}}}